LSTA FDA Decision CRL · 2025-01-22
Mislabel — certepetide Phase 2b ASCEND data, no CRL
Price into the decision (T-120)
Historical price action; green = local high, red = low/sell-off.
Decision facts
FDA decision date2025-01-22
Outcome✗ CRL⚠ label corrected
Decision-day move-29.5%
T-120 run-up (low→high)+23.0% ($2.43→$3.9)
CRL reasonMislabel — certepetide Phase 2b ASCEND data, no CRL
pdufa.bio · access required